KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organon (OGN) Operating Expenses (2020 - 2026)

Organon has reported Operating Expenses over the past 7 years, most recently at $548.0 million for Q1 2026.

  • For Q1 2026, Operating Expenses fell 8.97% year-over-year to $548.0 million; the TTM value through Mar 2026 reached $2.1 billion, down 6.46%, while the annual FY2025 figure was $2.2 billion, 3.45% down from the prior year.
  • Operating Expenses for Q1 2026 was $548.0 million at Organon, up from $531.0 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $1.5 billion in Q4 2023 and troughed at $499.0 million in Q3 2025.
  • A 5-year average of $966.5 million and a median of $1.1 billion in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: grew 15.82% in 2023 and later crashed 64.42% in 2024.
  • Year by year, Operating Expenses stood at $1.4 billion in 2022, then grew by 8.73% to $1.5 billion in 2023, then crashed by 59.3% to $608.0 million in 2024, then decreased by 12.66% to $531.0 million in 2025, then grew by 3.2% to $548.0 million in 2026.
  • Business Quant data shows Operating Expenses for OGN at $548.0 million in Q1 2026, $531.0 million in Q4 2025, and $499.0 million in Q3 2025.